Destrocell drug unveiling ceremony

October  26rd

Destrocell drug unveiling ceremony on Thursday,October  27rd, 2024 with the presence of the head of the Charity foundation of  Special Diseases, the head of the Food and Drug Organization of the Ministry of Health, the deputy official of the Refah Bank and the representative of Sweden's Suiko company (online) hosted by the Tashgin bioregenerative science foundation company was held.

According to the Public Relations o the Charity foundation of  Special Diseases, Dr. Nasser Aghdami, the CEO of Tasgin Bioregeneration Company, presented a report on the various research stages of the destrocell drug in Sweden and its production in the country.

It is worth mentioning that supporting the production of this medicine is one of the public benefit activities of the Nazari family, who are currently building the Tasgin Rafsanjan Hospital, which is one of the latest reconstruction activities, a dynamic and innovative field that uses the principles of biology and engineering. . In this field, it tries to reconstruct and change the structure of things on a molecular to cellular scale. This process plays a significant role not only in the field of medicine and treatment, but also in the production of other cases. It benefits from new solutions for complex social and environmental issues.